Cannabis Bioscience International Holdings, Inc.
CBIH
$0.00
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 120.25% | -30.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 120.25% | -30.86% | |||
| Cost of Revenue | 29.63% | 80.00% | |||
| Gross Profit | 165.84% | -47.04% | |||
| SG&A Expenses | 52.64% | -40.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 50.61% | -37.30% | |||
| Operating Income | -28.21% | 39.19% | |||
| Income Before Tax | -41.65% | 60.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -41.65% | 60.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -41.65% | 60.98% | |||
| EBIT | -28.21% | 39.19% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.00% | 4.34% | |||
| Average Diluted Shares Outstanding | 0.00% | 4.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||